IsoGeniX is a biodiversity intelligence company. We build the data
infrastructure that connects high-quality genetic and ecological
information from the world's most biodiverse regions with the pharma,
agritech and AI companies that need it.

The next generation of biological AI models, drug discovery pipelines
and crop science programmes are constrained by a single bottleneck:
access to diverse, high-quality genetic data from nature. Public
sequence databases are incomplete, biased toward a handful of
well-studied species and geographies, and increasingly misaligned with
the access and benefit-sharing frameworks of the Nagoya Protocol and
the Convention on Biological Diversity.

IsoGentiX solves this. Our platform  built on the Nagoya Protocol,
creates a verified, compliant and scalable pathway from biodiversity-
rich source countries to commercial end-users. We combine field-level
data collection infrastructure, rigorous verification and AI-powered
analytics to deliver biodiversity intelligence that meets the
scientific, regulatory and ethical standards the industry demands.

Founded by entrepreneurs with decades of experience building
data-intensive, regulation-driven technology ventures across frontier
markets, IsoGentiX is headquartered in the UK with operations in
Africa and developing partnerships spanning pharma, agricultural science; 
computational biology and AI LLMs

We are backed by [investors / currently raising — update as
appropriate].

IsoGentiX

Org chart

Teams

Offices

IsoGentiX

Org chart

Teams

Offices

Related companies